{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:59Z","timestamp":1793686379792,"version":"4.5.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To compare the rapid bedside test for placental \u03b1 microglobulin-1 with the instrumented fetal fibronectin test for prediction of imminent spontaneous preterm delivery among women with symptoms of preterm labor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a prospective observational study on pregnant women with signs or symptoms suggestive of preterm labor between 24 and 35 weeks of gestation with intact membranes and cervical dilatation less than 3 cm. Participants were prospectively enrolled at 15 U.S. academic and community centers. Placental \u03b1 microglobulin-1 samples did not require a speculum examination. Health care providers were blinded to placental \u03b1 microglobulin-1 results. Fetal fibronectin samples were collected through speculum examination per manufacturer requirements and sent to a certified laboratory for testing using a cutoff of 50 ng\/mL. The coprimary endpoints were positive predictive value (PPV) superiority and negative predictive value (NPV) noninferiority of placental \u03b1 microglobulin-1 compared with fetal fibronectin for the prediction of spontaneous preterm birth within 7 days and within 14 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 796 women included in the study cohort, 711 (89.3%) had both placental \u03b1 microglobulin-1 and fetal fibronectin results and valid delivery outcomes available for analysis. The overall rate of preterm birth was 2.4% (17\/711) within 7 days of testing and 4.2% (30\/711) within 14 days of testing with respective rates of spontaneous preterm birth of 1.3% (9\/703) and 2.9% (20\/701). Fetal fibronectin was detected in 15.5% (110\/711), and placental \u03b1 microglobulin-1 was detected in 2.4% (17\/711). The PPVs for spontaneous preterm delivery within 7 days or less among singleton gestations (n=13) for placental \u03b1 microglobulin-1 and fetal fibronectin were 23.1% (3\/13) and 4.3% (4\/94), respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.025 for superiority). The NPVs were 99.5% (619\/622) and 99.6% (539\/541) for placental \u03b1 microglobulin-1 and fetal fibronectin, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001 for noninferiority).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Although placental \u03b1 microglobulin-1 performed the same as fetal fibronectin in ruling out spontaneous preterm delivery among symptomatic women, it demonstrated statistical superiority in predicting it.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002367","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:36Z","timestamp":1511378016000},"page":"1183-1191","source":"Crossref","is-referenced-by-count":48,"title":["Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women"],"prefix":"10.1097","volume":"130","author":[{"given":"Deborah A.","family":"Wing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Haeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C.","family":"Silber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl K.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson C.","family":"Echebiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanissa M.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Yeast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelle A.","family":"Brebnor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gerald","family":"Quirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy T.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2003.11.034","article-title":"Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial","volume":"191","author":"Grobman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9378(97)70431-9","article-title":"Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial","volume":"177","author":"Peaceman","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"217.e1","DOI":"10.1016\/j.ajog.2013.06.046","article-title":"Costs of unnecessary admissions and treatments for \u201cthreatened preterm labor\u201d","volume":"209","author":"Lucovnik","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajog.2016.07.057","article-title":"Fetal fibronectin testing in threatened preterm labor: time to stop","volume":"215","author":"Macones","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1067\/mob.2003.390","article-title":"Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms","volume":"188","author":"Plaut","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0884217504267270","article-title":"The utility of fFN for the prediction of preterm birth in twin gestations","volume":"33","author":"Ruiz","year":"2004","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R7-20230711","first-page":"369","article-title":"Placental alpha microglobulin-1 protein linking somatomedins","volume":"109","author":"Tatarinov","year":"1990","journal-title":"Successes Mod Biol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3109\/14767058.2012.657279","article-title":"The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes","volume":"25","author":"Lee","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1515\/jpm-2014-0300","article-title":"Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor","volume":"43","author":"Nikolova","year":"2015","journal-title":"J Perinat Med"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0006-341X.2000.00345.x","article-title":"Comparisons of predictive values of binary medical diagnostic tests for paired designs","volume":"56","author":"Leisenring","year":"2000","journal-title":"Biometrics"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/AOG.0000000000001711","article-title":"Management of preterm labor. Practice Bulletin No. 171. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajog.2016.04.038","article-title":"Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials","volume":"215","author":"Berghella","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1515\/jpm-2013-0234","article-title":"Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery","volume":"42","author":"Nikolova","year":"2014","journal-title":"J Perinat Med"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.gyobfe.2015.07.002","article-title":"Preterm labor: reproducibility of detection test of PAMG-1 before and after digital examination, and transvaginal ultrasound cervical length [in French]","volume":"43","author":"Werlen","year":"2015","journal-title":"Gynecol Obstet Fertil"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201712000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T18:06:33Z","timestamp":1689098793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201712000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002367","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}